Clinical Research of Philadelphia

Clinical Research of Philadelphia

Philadelphia, United States· Est. 1996

Clinical Research of Philadelphia (CRP) is a well-established, privately-held clinical research site that has been serving the Philadelphia community for nearly three decades. The company's mission is to advance medical research by connecting diverse patient populations with clinical trials, leveraging partnerships with over 50 community-based providers to access a potential patient pool of over 600,000. CRP has built a strong reputation for operational excellence, having enrolled over 10,000 participants since its founding, and focuses on therapeutic areas with high unmet need, including metabolic dysfunction-associated steatotic liver disease (MASLD), cardiovascular risk, type 2 diabetes, and women's health conditions. Their patient-centric approach, technological infrastructure, and experienced team position them as a preferred site for pharmaceutical sponsors.

Private Company

Funding information not available

AI Company Overview

Clinical Research of Philadelphia (CRP) is a well-established, privately-held clinical research site that has been serving the Philadelphia community for nearly three decades. The company's mission is to advance medical research by connecting diverse patient populations with clinical trials, leveraging partnerships with over 50 community-based providers to access a potential patient pool of over 600,000. CRP has built a strong reputation for operational excellence, having enrolled over 10,000 participants since its founding, and focuses on therapeutic areas with high unmet need, including metabolic dysfunction-associated steatotic liver disease (MASLD), cardiovascular risk, type 2 diabetes, and women's health conditions. Their patient-centric approach, technological infrastructure, and experienced team position them as a preferred site for pharmaceutical sponsors.

Metabolic DiseaseWomen's HealthDermatologyRheumatologyNeurologyCardiovascular

Technology Platform

Operational platform centered on a fully electronic Clinical Trial Management System (CTMS) for streamlined trial execution, remote monitoring, and data management, supported by a dedicated 4,000 sq. ft. research facility.

Opportunities

Growth is driven by the expanding global clinical trials market, increased demand for diverse patient populations, and the trend towards community-embedded research.
Opportunities exist for geographic expansion, deeper specialization in high-need therapeutic areas like MASLD, and leveraging their operational technology for further efficiency gains or potential commercialization.

Risk Factors

Key risks include dependency on pharmaceutical sponsor contracts, regulatory and compliance challenges inherent to clinical research, intense competition for patient recruitment, and reliance on key Principal Investigators.
Economic downturns could also impact sponsor R&D budgets.

Competitive Landscape

CRP competes with academic medical center sites and other private research organizations in the Philadelphia region. Its main differentiators are deep community integration via 50+ provider partnerships, operational agility as a private entity, a 28-year track record of over 500 trials, investment in a fully electronic CTMS, and a team of specialized, board-certified investigators.